✦ LIBER ✦

Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis

✍ Scribed by B. Jönsson, O. Ström, J. A. Eisman, A. Papaioannou, E. S. Siris, A. Tosteson, J. A. Kanis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of Denosumab for the

✍ B. Jönsson; O. Ström; J. A. Eisman; A. Papaioannou; E. S. Siris; A. Tosteson; J. 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 336 KB

Cost-effectiveness of denosumab in the t

✍ Chau, D.; Becker, D. L.; Coombes, M. E.; Ioannidis, G.; Adachi, J. D.; Goeree, R 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 282 KB

PMS44 Cost-Effectiveness of Denosumab in

✍ A. Davies; J. Compston; S. Ferguson; E. McClosky; A. Shearer; A. Taylor 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Denosumab for treatment of postmenopausa

✍ Chitre, M.; Shechter, D.; Grauer, A. 📂 Article 📅 2011 🏛 American Society of Health-System Pharmacists 🌐 English ⚖ 224 KB

Denosumab for the treatment of postmenop

✍ Lewiecki, E Michael 📂 Article 📅 2009 🏛 Future Medicine 🌐 English ⚖ 731 KB

Potential cost-effectiveness of denosuma

✍ Mickaël Hiligsmann; Jean-Yves Reginster 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 411 KB